Publications by authors named "Atif Hussein"

Claim this Profile
B
Bispecific Antibodies in Solid Tumors: Advances and Challenges.
Khine Swe Shan, Saba Musleh Ud Din, Shivani Dalal, Teresita Gonzalez, Misha Dalal, Atif Hussein

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Fusions in NSCLC: From Mechanisms to Clinical Applications.
Nyein Wint Yee Theik, Suset Almuinas De Armas, Daniel Rosas, Amy Kiamos, Nyein Nyein Thaw Dar, Atif Hussein

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Timing in Immunotherapy: A Systematic Review.
Stephanie Nagy, Atif Hussein, Marc M Kesselman

Cureus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Antihistamines on Immunotherapy: A Systematic Review.
Stephanie Nagy, Oksana Denis, Atif Hussein, Marc M Kesselman

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Targeting of the Isocitrate Dehydrogenase Pathway and the Implications for Cancer Therapy.
Stanislav Ivanov, Olger Nano, Caroline Hana, Amalia Bonano-Rios, Atif Hussein

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of Diabetes and Diabetic Ketoacidosis Following Immunotherapy Treatment: A Systematic Review of Case Reports.
Stephanie Nagy, Michelle Demory Beckler, Atif Hussein, Marc M Kesselman

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers.
Khine S Shan, Amalia Bonano-Rios, Nyein Wint Yee Theik, Atif Hussein, Marcelo Blaya

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer.
Saba Musleh Ud Din, Spencer G Streit, Bao Tran Huynh, Caroline Hana, Anna-Ninny Abraham, Atif Hussein

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Therapy among Different Types of Cancers, Review and Future Perspectives.
Nyein Wint Yee Theik, Meri Muminovic, Andres M Alvarez-Pinzon, Ahmed Shoreibah, Atif M Hussein

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of CD4/6 Inhibitors in Breast Cancer Treatment.
Luv Purohit, Can Jones, Teresita Gonzalez, Aurelio Castrellon, Atif Hussein

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Immunotherapy in Sarcomas.
Shivani Dalal, Khine Swe Shan, Nyein Nyein Thaw Dar, Atif Hussein, Alejandra Ergle

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue "From Basic Science to Treatment Strategies: Personalized Cancer Therapy".
Meri Muminovic, Atif Hussein, Luis E Raez

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
Nimish Thakral, Teresita Gonzalez, Olger Nano, Sang-Ha Shin, Shenae Samuels, Atif Hussein

BMC Gastroenterol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic adverse events in patients treated with immune checkpoint inhibitors.
Caroline Hana, Tauseef Rehman, Kyeeun Park, Carlos Carracedo Uribe, Pyi Phyo Aung, Atif Hussein

JGH Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and prognostic factors in hospitalized COVID-19 patients with cancer: an analysis from a large healthcare system in the United States.
Luis E Raez, Meri Tarockoff, Carlos Rodrigo Carracedo Uribe, Jianli Niu, Candice Sareli, Atif Hussein

Ann Transl Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis.
Andrea Espejo-Freire, Andrew Elliott, Andrew Rosenberg, Philippos Apolinario Costa, Priscila Barreto-Coelho, Atif Mahmoud Hussein

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
James J Vredenburgh, David Coniglio, Gloria Broadwater, Roy B Jones, Maureen Ross, Atif Hussein

Biol Blood Marrow Transplant· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes.
Monic J Stuart, William P Peters, Gloria Broadwater, Atif Hussein, Maureen Ross

Biol Blood Marrow Transplant· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis